Search Share Prices
AZN Headlines - Head and Neck Squamous Cell Carcinoma (HNSCC) Treatment and Drugs Market Outlook, Size, Demand, Competitive Analysis, And Growth Factors
Hoffmann-La Roche Ltd (SWX: RO), Eli Lilly and Company (NYSE: LLY), Bristol-Myers Squibb Company (NYSE: BMY), AstraZeneca plc (LON: AZN), Merck Sharp & Dohme Corp. (Merck & Co., Inc.) (NYSE: MRK), ...
NetScientific tops the risers after deal with AstraZeneca
NetScientific PLC's , up 235 at 92p, was the top riser after striking a licensing deal with AstraZeneca PLC . Its ProAxsis subsidiary is to work with AstraZeneca over the validati ...
NetScientific's ProAxsis to validate and commercialise AstraZeneca's coronavirus vaccine assay
It is envisaged that the validation and initial commercialisation can be achieved largely from ProAxsis' existing resources ...
Leerink Partners Stick to Their Buy Rating for Astrazeneca Plc
Leerink Partners analyst Andrew Berens maintained a Buy rating on Astrazeneca Plc (LON:AZN) on Friday, setting a price target of $64, which is approximately 13.78% above the present share price of $56 ...
Dementia and Alzheimer's Disease Treatment Market Forecast With Trends, Challenges & Drivers and Key Players
Research Nester released a report titled "Dementia and Alzheimer's Disease Treatment Market: Global Demand Analysis ...